Zacks.com on MSN1h
BIO Q4 Earnings and Revenues Miss Estimates, Stock Down Aftermarket
Bio-Rad Laboratories, Inc. BIO posted fourth-quarter 2024 adjusted earnings per share (EPS) of $2.90, which missed the Zacks ...
Lewiston Tribune1d
Call for vendors and memorabilia
Lewis-Clark State College’s Center for Arts & History is seeking Avista NAIA World Series memorabilia for an upcoming ...
Cardinal Health Inc. stock outperforms competitors despite losses on the day
Cardinal Health Inc. closed 4.35% short of its 52-week high of $132.84, which the company achieved on January 30th.
Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.5056
The board of Cardinal Health, Inc. ( NYSE:CAH ) has announced that it will pay a dividend on the 15th of April, ...
FiercePharma4d
With Teva competition heating up, Neurocrine's tame Ingrezza forecast spooks investors
Despite the recent launch of congenital adrenal hyperplasia (CAH) drug Crenessity, Neurocrine Biosciences' disappointing ...
Barchart on MSN4d
Are Wall Street Analysts Predicting Cardinal Health Stock Will Climb or Sink?
Dublin, Ohio-based Cardinal Health, Inc. (CAH) manufactures and distributes pharmaceuticals, medical & laboratory products, ...
With 88% ownership in Cardinal Health, Inc. (NYSE:CAH), institutional investors have a lot riding on the business
Key Insights Given the large stake in the stock by institutions, Cardinal Health's stock price might be vulnerable ...
Cardinal Health (NYSE:CAH) Upgraded by Jefferies Financial Group to “Buy” Rating
Jefferies Financial Group upgraded shares of Cardinal Health (NYSE:CAH – Free Report) from a hold rating to a buy rating in a report released on Wednesday morning, Marketbeat reports. The brokerage ...